Large Cap · Healthcare · Healthcare Plans
Large Cap · Healthcare · Healthcare Plans
Get the AI take on CVS
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
56/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Current price
$94.91
Lowest
$103
Median target
$116
Highest
$148
Forward P/E
Favorable · 32% below avg
11.92x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.30x
Price / FCF
Strong · Priced well within what its cash flow supports
10.57x
EV / EBITDA
Strong · Operating earnings comfortably support this price
11.19x
ROIC
Weak · Struggling to earn much on the capital it uses
7.2%
ROE
Needs attention · Unfavorable
6.2%
Debt / equity
Middle ground · Mixed
0.96x
Current ratio
Weak · Not enough on hand to cover near-term bills
0.87x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $124.26B | 25.6 | +7.4% | 56 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |